---
$id: https://graph.org.ai/products/commodity/51282308
$type: Product
source: UNSPSC
code: "51282308"
title: "Roxithromycin"
class: "51282300"
classTitle: "Erythromycins"
family: "51280000"
familyTitle: "Antibacterials"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Roxithromycin

**UNSPSC Code**: 51282308
**Class**: [Erythromycins](Erythromycins.mdx)
**Family**: [Antibacterials](../Antibacterials.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a macrolide antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 21KOF230FA. European Medicines Agency schedules Roxithromycin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10400MIG. Roxithromycin generally arises in the molecular formula C41H76N2O15. The term ROXITHROMYCIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, no. 6, 1986, list 26.) ROXITHROMYCIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule roxithromycin under HS 29415000 and SITC 54139. As of Q4 2014, ROXITHROMYCIN remains the US FDA Preferred Term for this commodity. Roxithromycin bears US NLM identifiers UMLS ID C0035891 and NCI Concept Code C818. SMILES: O(C1C(C(OC2OC(C(O)C(OC)(C2)C)C)C(C(=O)OC(C(O)(C(O)C(C(=N\OCOCCOC)/C(CC1(O)C)C)C)C)CC)C)C)C1OC(CC(N(C)C)C1O)C.

